Black Rock Inc. Zentalis Pharmaceuticals, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Zentalis Pharmaceuticals, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 4,645,758 shares of ZNTL stock, worth $55.2 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

4,645,758

Previous 4,684,975 0.84%

Holding current value

$55.2 Million

Previous $71 Million 3.16%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	SELL	$10.83 - $16.49 $424,720 - $646,688	-39,217 Reduced 0.84%	4,645,758 $73.2 Million
Q4 2023 Feb 13, 2024	BUY	$9.84 - $20.13 $2.84 Million - $5.82 Million	289,118 Added 6.58%	4,684,975 $71 Million
Q3 2023 Nov 13, 2023	BUY	$19.63 - $28.29 $8.74 Million - $12.6 Million	445,053 Added 11.26%	4,395,857 $88.2 Million
Q2 2023 Aug 11, 2023	BUY	$17.41 - $30.05 $9.29 Million - $16 Million	533,337 Added 15.61%	3,950,804 $111 Million
Q1 2023 May 12, 2023	SELL	$16.14 - $24.94 $883,051 - $1.36 Million	-54,712 Reduced 1.58%	3,417,467 $58.8 Million

Q4 2022 Feb 13, 2023	BUY	$18.07 - $25.6 $2.46 Million - $3.48 Million	136,113 Added 4.08%	3,472,179 $69.9 Million
Q3 2022 Nov 14, 2022	BUY	$20.23 - $31.73 $1.92 Million - $3.01 Million	95,008 Added 2.93%	3,336,066 $72.3 Million
Q2 2022 Aug 12, 2022	BUY	$17.91 - $52.25 $7.14 Million - $20.8 Million	398,478 Added 14.02%	3,241,058 $91.1 Million
Q1 2022 May 12, 2022	SELL	$41.58 - $80.89 $15,176 - $29,524	-365 Reduced 0.01%	2,842,580 $131 Million
Q4 2021 Feb 10, 2022	BUY	$66.92 - $84.79 $5.83 Million - $7.39 Million	87,157 Added 3.16%	2,842,945 $239 Million
Q3 2021 Nov 09, 2021	BUY	$46.83 - $73.5 $20.4 Million - $32 Million	435,672 Added 18.78%	2,755,788 $184 Million
Q2 2021 Aug 11, 2021	BUY	$37.41 - $62.25 $86.8 Million - $144 Million	2,320,116 New	2,320,116 $123 Million

Others Institutions Holding ZNTL

# of Institutions

142

Shares Held

76.3M

Call Options Held

68.2K

Put Options Held

2.3K

View Full List

About Zentalis Pharmaceuticals, Inc.

Ticker ZNTL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,983,600
Market Cap $677M
Description
Zentalis Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics for the treatment of various cancers. Its lead product candidate includes the ZN-c3, an inhibitor of WEE1, a protein tyrosine kinase, which is in Phase 2 clinical trial for the treatment of advanced solid ...

More about ZNTL

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account